| Year |
Citation |
Score |
| 2022 |
Abd Alla J, Quitterer U. The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart. Cells. 11. PMID 35203304 DOI: 10.3390/cells11040654 |
0.327 |
|
| 2019 |
Perhal A, Wolf S, Jamous YF, Langer A, Abd Alla J, Quitterer U. Increased Reactive Oxygen Species Generation Contributes to the Atherogenic Activity of the B2 Bradykinin Receptor. Frontiers in Medicine. 6: 32. PMID 30847343 DOI: 10.3389/Fmed.2019.00032 |
0.352 |
|
| 2019 |
Quitterer U, AbdAlla S. Discovery of Pathologic GPCR Aggregation. Frontiers in Medicine. 6: 9. PMID 30761305 DOI: 10.3389/Fmed.2019.00009 |
0.506 |
|
| 2019 |
Perhal A, Wolf S, Langer A, Quitterer U. The bradykinin B2 receptor enhances atherosclerotic lesion formation in hypercholesterolemic ApoE-deficient mice Naunyn-Schmiedebergs Archives of Pharmacology. 392. PMID 30737535 DOI: 10.1007/S00210-019-01621-6 |
0.348 |
|
| 2019 |
Quitterer U, Fu X, Pohl A, Bayoumy KM, Langer A, AbdAlla S. Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers. Cell. 176: 318-333.e19. PMID 30503206 DOI: 10.1016/J.Cell.2018.10.050 |
0.392 |
|
| 2018 |
Wolf S, Abd Alla J, Quitterer U. Sensitization of the Angiotensin II AT1 Receptor Contributes to RKIP-Induced Symptoms of Heart Failure. Frontiers in Medicine. 5: 359. PMID 30687708 DOI: 10.3389/Fmed.2018.00359 |
0.403 |
|
| 2016 |
Alla JA, Langer A, Quitterer U. Down-regulation of the chemokine (c-c motif) receptor 9 (Ccr9) contributes to the atherosclerosis-lowering activity of the angiotensin-converting enzyme inhibitor captopril Atherosclerosis. 252. DOI: 10.1016/J.Atherosclerosis.2016.07.432 |
0.361 |
|
| 2015 |
Abd Alla J, Graemer M, Fu X, Quitterer U. Inhibition of G-protein-coupled receptor kinase 2 prevents the dysfunctional cardiac substrate metabolism in fatty acid synthase-transgenic mice. The Journal of Biological Chemistry. PMID 26670611 DOI: 10.1074/Jbc.M115.702688 |
0.367 |
|
| 2014 |
Quitterer U, AbdAlla S. Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer. Biochemical Pharmacology. 88: 284-90. PMID 24462918 DOI: 10.1016/J.Bcp.2014.01.019 |
0.474 |
|
| 2013 |
AbdAlla S, Langer A, Fu X, Quitterer U. ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease. International Journal of Molecular Sciences. 14: 16917-42. PMID 23959119 DOI: 10.3390/Ijms140816917 |
0.316 |
|
| 2013 |
Fu X, Koller S, Abd Alla J, Quitterer U. Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. The Journal of Biological Chemistry. 288: 7738-55. PMID 23362259 DOI: 10.1074/Jbc.M112.428078 |
0.409 |
|
| 2011 |
Quitterer U, Pohl A, Langer A, Koller S, Abdalla S. A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor. Biochemical and Biophysical Research Communications. 409: 544-9. PMID 21600887 DOI: 10.1016/J.Bbrc.2011.05.041 |
0.516 |
|
| 2011 |
El Faramawy Y, Fu X, Agwa SH, Langer A, Elzahwy SS, Quitterer U. RKIP enhances angiotensin II-stimulated signaling Forum On Immunopathological Diseases and Therapeutics. 2: 71-78. DOI: 10.1615/Forumimmundisther.V2.I1.80 |
0.313 |
|
| 2010 |
Abd Alla J, Langer A, Elzahwy SS, Arman-Kalcek G, Streichert T, Quitterer U. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis. The Journal of Biological Chemistry. 285: 23496-505. PMID 20504763 DOI: 10.1074/Jbc.M110.117481 |
0.366 |
|
| 2010 |
Abd Alla J, Pohl A, Reeck K, Streichert T, Quitterer U. Establishment of an in vivo model facilitates B2 receptor protein maturation and heterodimerization. Integrative Biology : Quantitative Biosciences From Nano to Macro. 2: 209-17. PMID 20473401 DOI: 10.1039/B922592G |
0.5 |
|
| 2009 |
Abd Alla J, Reeck K, Langer A, Streichert T, Quitterer U. Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization. Biochemical and Biophysical Research Communications. 387: 186-90. PMID 19580784 DOI: 10.1016/J.Bbrc.2009.07.011 |
0.451 |
|
| 2009 |
AbdAlla S, Lother H, el Missiry A, Langer A, Sergeev P, el Faramawy Y, Quitterer U. Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. The Journal of Biological Chemistry. 284: 6554-65. PMID 19074441 DOI: 10.1074/Jbc.M807746200 |
0.379 |
|
| 2009 |
AbdAlla S, Lother H, el Missiry A, Sergeev P, Langer A, el Faramawy Y, Quitterer U. Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. The Journal of Biological Chemistry. 284: 6566-74. PMID 19074439 DOI: 10.1074/Jbc.M808277200 |
0.49 |
|
| 2006 |
Klenk C, Humrich J, Quitterer U, Lohse MJ. SUMO-1 controls the protein stability and the biological function of phosducin. The Journal of Biological Chemistry. 281: 8357-64. PMID 16421094 DOI: 10.1074/Jbc.M513703200 |
0.545 |
|
| 2005 |
AbdAlla S, Abdel-Baset A, Lother H, el Massiery A, Quitterer U. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. Journal of Molecular Neuroscience : Mn. 26: 185-92. PMID 16012192 DOI: 10.1385/Jmn:26:2-3:185 |
0.445 |
|
| 2005 |
Humrich J, Bermel C, Bünemann M, Härmark L, Frost R, Quitterer U, Lohse MJ. Phosducin-like protein regulates G-protein betagamma folding by interaction with tailless complex polypeptide-1alpha: dephosphorylation or splicing of PhLP turns the switch toward regulation of Gbetagamma folding. The Journal of Biological Chemistry. 280: 20042-50. PMID 15745879 DOI: 10.1074/Jbc.M409233200 |
0.633 |
|
| 2004 |
AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell. 119: 343-54. PMID 15507206 DOI: 10.1016/J.Cell.2004.10.006 |
0.476 |
|
| 2004 |
Quitterer U, Lother H, Abdalla S. AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Seminars in Nephrology. 24: 115-9. PMID 15017523 DOI: 10.1016/J.Semnephrol.2003.11.007 |
0.433 |
|
| 2003 |
Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature. 426: 574-9. PMID 14654844 DOI: 10.1038/Nature02158 |
0.621 |
|
| 2003 |
Eichmann T, Lorenz K, Hoffmann M, Brockmann J, Krasel C, Lohse MJ, Quitterer U. The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site. The Journal of Biological Chemistry. 278: 8052-7. PMID 12486133 DOI: 10.1074/Jbc.M204795200 |
0.58 |
|
| 2003 |
Humrich J, Bermel C, Grubel T, Quitterer U, Lohse MJ. Regulation of phosducin-like protein by casein kinase 2 and N-terminal splicing. The Journal of Biological Chemistry. 278: 4474-81. PMID 12466282 DOI: 10.1074/Jbc.M206347200 |
0.475 |
|
| 2002 |
Englert M, Quitterer U, Klotz KN. Effector coupling of stably transfected human A3 adenosine receptors in CHO cells. Biochemical Pharmacology. 64: 61-5. PMID 12106606 DOI: 10.1016/S0006-2952(02)01071-7 |
0.449 |
|
| 2001 |
AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nature Medicine. 7: 1003-9. PMID 11533702 DOI: 10.1038/Nm0901-1003 |
0.488 |
|
| 2001 |
AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. The Journal of Biological Chemistry. 276: 39721-6. PMID 11507095 DOI: 10.1074/jbc.M105253200 |
0.388 |
|
| 2001 |
Quitterer U, Hoffmann M, Freichel M, Lohse MJ. Paradoxical block of parathormone secretion is mediated by increased activity of G alpha subunits. The Journal of Biological Chemistry. 276: 6763-9. PMID 11102444 DOI: 10.1074/jbc.M007727200 |
0.54 |
|
| 2000 |
AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 407: 94-8. PMID 10993080 DOI: 10.1038/35024095 |
0.519 |
|
| 2000 |
Ruiz-Gómez A, Humrich J, Murga C, Quitterer U, Lohse MJ, Mayor F. Phosphorylation of phosducin and phosducin-like protein by G protein-coupled receptor kinase 2. The Journal of Biological Chemistry. 275: 29724-30. PMID 10884381 DOI: 10.1074/Jbc.M001864200 |
0.578 |
|
| 1999 |
Slupsky JR, Quitterer U, Weber CK, Gierschik P, Lohse MJ, Rapp UR. Binding of Gbetagamma subunits to cRaf1 downregulates G-protein-coupled receptor signalling. Current Biology : Cb. 9: 971-4. PMID 10508586 DOI: 10.1016/S0960-9822(99)80426-6 |
0.623 |
|
| 1999 |
Quitterer U, Lohse MJ. Crosstalk between Galpha(i)- and Galpha(q)-coupled receptors is mediated by Gbetagamma exchange. Proceedings of the National Academy of Sciences of the United States of America. 96: 10626-31. PMID 10485876 DOI: 10.1073/Pnas.96.19.10626 |
0.623 |
|
| 1999 |
AbdAlla S, Zaki E, Lother H, Quitterer U. Involvement of the amino terminus of the B(2) receptor in agonist-induced receptor dimerization. The Journal of Biological Chemistry. 274: 26079-84. PMID 10473556 DOI: 10.1074/Jbc.274.37.26079 |
0.476 |
|
| 1999 |
Quitterer U, Zaki E, AbdAlla S. Investigation of the extracellular accessibility of the connecting loop between membrane domains I and II of the bradykinin B2 receptor. The Journal of Biological Chemistry. 274: 14773-8. PMID 10329674 DOI: 10.1074/Jbc.274.21.14773 |
0.439 |
|
| 1999 |
Dicker F, Quitterer U, Winstel R, Honold K, Lohse MJ. Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases. Proceedings of the National Academy of Sciences of the United States of America. 96: 5476-81. PMID 10318908 DOI: 10.1073/Pnas.96.10.5476 |
0.647 |
|
| 1996 |
AbdAlla S, Jarnagin K, Müller-Esterl W, Quitterer U. The N-terminal amino group of [Tyr8]bradykinin is bound adjacent to analogous amino acids of the human and rat B2 receptor. The Journal of Biological Chemistry. 271: 27382-7. PMID 8910316 DOI: 10.1074/jbc.271.44.27382 |
0.329 |
|
| 1996 |
Quitterer U, AbdAlla S, Jarnagin K, Müller-Esterl W. Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation. Biochemistry. 35: 13368-77. PMID 8873604 DOI: 10.1021/bi961163w |
0.379 |
|
| 1996 |
AbdAlla S, Godovac-Zimmermann J, Braun A, Roscher AA, Müller-Esterl W, Quitterer U. Structure of the bradykinin B2 receptors' amino terminus. Biochemistry. 35: 7514-9. PMID 8652530 DOI: 10.1021/Bi9601060 |
0.45 |
|
| 1994 |
Tippmer S, Quitterer U, Kolm V, Faussner A, Roscher A, Mosthaf L, Müller-Esterl W, Häring H. Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta. European Journal of Biochemistry / Febs. 225: 297-304. PMID 7925449 DOI: 10.1111/j.1432-1033.1994.00297.x |
0.409 |
|
| 1993 |
Alla SA, Buschko J, Quitterer U, Maidhof A, Haasemann M, Breipohl G, Knolle J, Müller-Esterl W. Structural features of the human bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic antibodies. The Journal of Biological Chemistry. 268: 17277-85. PMID 8394337 |
0.364 |
|
| Show low-probability matches. |